News

29/05/2025
Cadherin 17 is a new target for the efficient and safe treatment of colorectal cancer liver metastases using CAR-T cell therapy
In a study published in Science Translational Medicine, researchers from the Innovative Immunotherapies Lab, led by Doctor Monica Casucci at IRCCS San Raffaele Hospital, have identified the adhesion molecule cadherin 17 as a novel, cancer-specific antigen to treat liver metastases in colorectal cancer using CAR-T cells.
MORE
28/05/2025
Early post-natal trafficking of hematopoietic stem and progenitor cells enables in vivo gene therapy for treating genetic blood cell diseases
Researchers from SR-Tiget have identified an early post-natal window that enables lentiviral vector-mediated gene transduction of circulating hematopoietic stem and progenitor cells in vivo. The results have just been published in Nature.
MORE
23/05/2025
Immunobiotherapy of melanoma, between achievements and new perspectives
On the occasion of May 24, the European day dedicated to the prevention of melanoma, we interviewed Vincenzo Russo on the pathogenesis and treatment of this tumor.
MORE
02/05/2025
New Study from San Raffaele Scientists Featured on the Cover of The EMBO Journal
Congratulations to the teams of Professor Mirela Kuka and Professor Matteo Iannacone, whose paper “T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses” has been featured on the cover of The EMBO Journal.
MORE